800-872-2273

Clinical Trials and Studies

Your participation matters. Help us discover and cure!

Contact us at (800) USC-CARE (800-872-2273)

1482 Results for

Study Title Principal Investigator
Evaluating the Efficacy of a New Medication for Hidradenitis Suppurativa
The purpose of the study is to evaluate if a new investigational medication, Bimekizumab, works for patients with hidradenitis suppurativa (HS). Earlier studies of Bimekizumab have shown that the medication is effective in patients with HS. This study compares the effects of Bimekizumab to an FDA-approved medicine, Adalimumab, and a placebo (no active medicine). To evaluate how well Bimekiumab works, we will perform a range of assessments to see how the severity of HS can decrease and quality of life could be improved.
Not yet recruiting | dermatology | Not Multisite
April W. Armstrong, MD MPH
View Research Profile
Phase 3 Study of Study to Evaluate Marqibo® in the Combination Chemotherapy in the Treatment of Subjects >or=60 Years Old With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
A phase 3, multicenter, randomized study to evaluate the substitution of Marqibo® (Vincristine Sulfate Liposomes Injection, VSLI) for standard Vincristine Sulfate Injection (VSI) in the induction, intensification, and maintenance phases of combination chemotherapy in the treatment of subjects >or= 60 years old with newly diagnosed acute lymphoblastic leukemia (ALL).
Terminated | Leukemia | Multisite
Susan O'Brien
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Terminated | Uveitis | Multisite
Damien Rodger
Powered by SC CTSI